149 related articles for article (PubMed ID: 38489711)
1. Establishment of Golgi apparatus-related genes signature to predict the prognosis and immunotherapy response in gastric cancer patients.
Liu R; Chu W; Liu X; Hong J; Wang H
Medicine (Baltimore); 2024 Mar; 103(11):e37439. PubMed ID: 38489711
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of Golgi apparatus-related signature for predicting prognosis and immunotherapy response in breast cancer.
Chen X; Tang P; Kong Y; Chen D; Tang K
J Cancer Res Clin Oncol; 2024 Feb; 150(2):61. PubMed ID: 38300336
[TBL] [Abstract][Full Text] [Related]
3. Molecular subtype identification and prognosis stratification based on golgi apparatus-related genes in head and neck squamous cell carcinoma.
Zhang A; He X; Zhang C; Tang X
BMC Med Genomics; 2024 Feb; 17(1):53. PubMed ID: 38365684
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of Golgi apparatus-related genes indicates prognosis and immune infiltration in osteosarcoma.
Zhang J; Liu J; Ding R; Miao X; Deng J; Zhao X; Wu T; Cheng X
Aging (Albany NY); 2024 Mar; 16(6):5249-5263. PubMed ID: 38460960
[TBL] [Abstract][Full Text] [Related]
5. Molecular subtype identification and signature construction based on Golgi apparatus-related genes for better prediction prognosis and immunotherapy response in hepatocellular carcinoma.
Sun L; Liu Z; Wu Z; Ning K; Hu J; Chen Z; Wu Z; Yin X
Front Immunol; 2023; 14():1113455. PubMed ID: 37051238
[TBL] [Abstract][Full Text] [Related]
6. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
7. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
8. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
10. Integrated single-cell RNA sequencing analysis reveals a mesenchymal stem cell-associated signature for estimating prognosis and drug sensitivity in gastric cancer.
Shen K; Chen B; Gao W
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11829-11847. PubMed ID: 37410142
[TBL] [Abstract][Full Text] [Related]
11. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma.
Song Z; Su M; Li X; Xie J; Han F; Yao J
BMC Gastroenterol; 2023 Dec; 23(1):432. PubMed ID: 38066437
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer.
Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C
Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494
[TBL] [Abstract][Full Text] [Related]
13. Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer.
Qiu F; Zhu Y; Shi Y; Ji J; Jin Y
Dis Markers; 2021; 2021():4251763. PubMed ID: 34804261
[TBL] [Abstract][Full Text] [Related]
14. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
15. Unfolded protein response signature unveils novel insights into breast cancer prognosis and tumor microenvironment.
Zhou N; Kong D; Lin Q; Yang X; Zhou D; Lou L; Huang F
Cancer Genet; 2023 Aug; 276-277():17-29. PubMed ID: 37343507
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
17. A new risk model based on a 11-m
Lei L; Li N; Yuan P; Liu D
BMC Cancer; 2022 Apr; 22(1):365. PubMed ID: 35382776
[TBL] [Abstract][Full Text] [Related]
18. Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients.
Hu B; Meng Y; Qu C; Wang BY; Xiu DR
Front Immunol; 2022; 13():1018413. PubMed ID: 36300104
[TBL] [Abstract][Full Text] [Related]
19. Identification of a basement membrane-related genes signature to predict prognosis, immune landscape and guide therapy in gastric cancer.
Liu ZY; Xin L
Medicine (Baltimore); 2023 Sep; 102(39):e35027. PubMed ID: 37773804
[TBL] [Abstract][Full Text] [Related]
20. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
Front Immunol; 2022; 13():951214. PubMed ID: 35967313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
